Selective serotonin reuptake inhibitors in the treatment of post traumatic stress disorder
Record ID 32010000999
English
Authors' objectives:
Selective serotonin reuptake inhibitors (SSRIs) were developed to reduce the symptoms of depression, and many SSRIs are currently marketed for the treatment of depression and anxiety. More recently, SSRIs have also been investigated for the treatment of posttraumatic stress disorder (PTSD).
Details
Project Status:
Completed
URL for project:
http://www.hayesinc.com
Year Published:
2010
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Humans
- Selective Serotonin Reuptake Inhibitors
- Stress Disorders, Post-Traumatic
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
2010 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.